These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7490525

  • 1. A 67 kDa protein mediates pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated insulin secretion in a hamster clonal beta-cell line.
    Kulkarni RN, Smith DM, Ghatei MA, Bloom SR.
    J Endocrinol; 1995 Oct; 147(1):121-30. PubMed ID: 7490525
    [Abstract] [Full Text] [Related]

  • 2. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Oct; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I, Gottschall PE, Arimura A.
    Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
    [Abstract] [Full Text] [Related]

  • 4. PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta.
    Hezareh M, Schlegel W, Rawlings SR.
    J Neuroendocrinol; 1996 May; 8(5):367-74. PubMed ID: 8736436
    [Abstract] [Full Text] [Related]

  • 5. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 6. PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion.
    Inagaki N, Kuromi H, Seino S.
    Ann N Y Acad Sci; 1996 Dec 26; 805():44-51; discussion 52-3. PubMed ID: 8993392
    [Abstract] [Full Text] [Related]

  • 7. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L, Ahrén B, Edgren G, Degerman E.
    Endocrinology; 2005 Feb 26; 146(2):744-50. PubMed ID: 15514088
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cells.
    Chik CL, Inukai T, Ogiwara T, Boyd H, Li B, Karpinski E, Ho AK.
    J Neurochem; 1996 Sep 26; 67(3):1005-13. PubMed ID: 8752106
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 26; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L.
    Endocrinology; 1995 May 26; 136(5):2088-98. PubMed ID: 7720658
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of action of VIP and PACAP in the stimulation of insulin release.
    Straub SG, Sharp GW.
    Ann N Y Acad Sci; 1996 Dec 26; 805():607-12. PubMed ID: 8993448
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide.
    Straub SG, Sharp GW.
    J Biol Chem; 1996 Jan 19; 271(3):1660-8. PubMed ID: 8576167
    [Abstract] [Full Text] [Related]

  • 18. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C.
    Endocrinology; 2000 Mar 19; 141(3):1158-67. PubMed ID: 10698193
    [Abstract] [Full Text] [Related]

  • 19. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F, Puech R, Bockaert J, Brabet P, Bertrand G.
    Endocrinology; 2002 Apr 19; 143(4):1253-9. PubMed ID: 11897681
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells.
    Yada T, Sakurada M, Ihida K, Nakata M, Murata F, Arimura A, Kikuchi M.
    J Biol Chem; 1994 Jan 14; 269(2):1290-3. PubMed ID: 8288592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.